SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001213900-19-007796
Filing Date
2019-05-03
Accepted
2019-05-03 16:31:13
Documents
6

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ff12019_canfitebiopharma.htm F-1 534696
2 FORM OF PLACEMENT AGENT WARRANT ISSUED BY CAN-FITE BIOPHARMA LTD. ON APRIL 4, 20 ff12019ex4-6_canfitebio.htm EX-4.6 130180
3 OPINION OF DORON, TIKOTZKY, KANTOR, GUTMAN, & AMIT GROSS, ISRAELI COUNSEL TO THE ff12019ex5-1_canfitebio.htm EX-5.1 32280
4 CONSENT OF KOST FORER GABBAY & KASIERER ff12019ex23-1_canfitebio.htm EX-23.1 3377
5 GRAPHIC img_001.jpg GRAPHIC 20914
6 GRAPHIC ex5-1_001.jpg GRAPHIC 27219
  Complete submission text file 0001213900-19-007796.txt   768130
Mailing Address 10 BAREKET STREET, KIRYAT MATALON P.O. BOX 7537 PETACH TIKVA L3 4951778
Business Address 10 BAREKET STREET, KIRYAT MATALON P.O. BOX 7537 PETACH TIKVA L3 4951778 972 39241114
Can-Fite BioPharma Ltd. (Filer) CIK: 0001536196 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: F-1 | Act: 33 | File No.: 333-231209 | Film No.: 19796647
SIC: 2834 Pharmaceutical Preparations